Clinical TrialsSearch results
Number of results: 604
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2009-04-01
Other
- Multicenter phase II study of modified FOLFOX6 and bevacizumab in chemonaive advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2008-11-10
Recruiting
- Long-term Study of SM-13496 (Lurasidone Hydrochloride) in Adolescent Subjects with Schizophrenia
- Schizophrenia
- Yabuuchi Kazuki
- 2021-07-28
Other
- ATB200/AT2221 Phase 3 Open-label Extension Study
- Pompe disease
- Wright Jacquelyn
- 2020-10-05
Other
- A Phase II Study of Combination Chemotherapy using TS-1 and Cisplatin with Concurrent Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Locally Advanced Non-Small Cell Lung Cancer
- West Japan Oncology Group
- 2008-09-12
Other
- Does gefitinib prolong the survival of adenocarcinoma patients against non-adeno non-small cell lung cancer? A retrospective study.
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-07-23
Other
- Lung Cancer Evaluation of TS-1 Study
- Previously untreated stageIIIB/IV NSCLC
- West Japan Oncology Group
- 2006-10-18
Other
- phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive disease small-cell lung cancer.
- extensive disease small-cell lung cancer
- West Japan Oncology Group
- 2005-09-05
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- Randomized phase III study of
nedaplatin plus docetaxel versus
cisplatin plus docetaxel
for advanced or relapsed squamous cell carcinoma of the lung
- squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2009-06-30